Specific Diagnostics Begins Demonstrations and Testing of the Reveal AST System
Specific Diagnostics have announced clinical demonstrations of the Reveal AST system will be conducted at a clinical laboratory in Amsterdam during the ECCMID conference April 13-16.
The Reveal AST™ system delivers phenotypic AST in an average of 4 hours, directly from positive blood culture or isolate dilutions. The system provides minimum inhibitory concentration (MIC) with wide antimicrobial coverage for bacteria species responsible for bloodstream and other acute infections. Current methodologies require 2 days to determine the effective antibiotic while Specific's Reveal AST solution provides antibiotic susceptibility results in hours, allowing same-shift impact. The demonstrations conducted during ECCMID for leading European clinical laboratory directors and partners will demonstrate this rapid AST performance with both spiked and clinical blood culture samples.
The simple and rapid sample preparation workflow, just a 2- minute simple dilution of a positive blood culture fluid, will be demonstrated as well as the intuitive and elegant touch screen controller of the Reveal system. The demonstrations will allow customers to directly assess the simplicity and capability of the Reveal system in advance of its availability for adoption in Europe upon issuance of CE-IVD registration, expected in Q4 2019.
Date Published: 2nd April 2019
Source article link: Specific Diagnostics
Oxford Nanopore To Distribute Clear
Steris Corporation Launches Spor-Klenz®